Some researches have demonstrated the prevalence of MSI in HNSCC, and the high mutational burden caused by MSI makes the tumor immunogenic and sensitive to anti-PD1 therapy [44, 45]. Here, PDCD1 is linked to head and neck squamous cell carcinoma.